GoodRx Holdings, Inc.

GDRXNASDAQHealthcareHealth Information Services

$3.36- (-)1Y −8.49%

As of Oct 16, 2026 close

Market cap: $1.22B
P/E (TTM): 75.08
Forward P/E: 148.52
Dividend yield: -
52-week range: $1.77$4.30
Volume (live): -
Avg. volume (3M): 852.46K

GoodRx Holdings, Inc. (GDRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for GoodRx Holdings, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Hold

Based on 11 unique analysts

(12 total ratings in last 90 days)

High Confidence2.0:1 Buy/Sell

Average Price Target

$4.21

+25.30% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest GDRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 15, 2026	Allen Lutz	BofA Securities	Maintains	Sell	$2.65
Aug 20, 2026	Glen Santangelo	Barclays	Maintains	Sell	$3.00 → $4.00 +1.00 (+33.3%)
Aug 14, 2026	Jailendra Singh	Truist	Reiterates	Hold	-
Aug 13, 2026	Kevin Caliendo	UBS	Maintains	Hold	$2.50 → $3.75 +1.25 (+50.0%)
Aug 11, 2026	Charles Rhyee	TD Cowen	Reiterates	Buy	$4.00 → $5.00 +1.00 (+25.0%)
Aug 11, 2026	Daniel Grosslight	Citi	Maintains	Buy	$4.00 → $5.00 +1.00 (+25.0%)
Aug 10, 2026	Daniel Grosslight	Citi	Maintains	Buy	$4.00 → $5.00 +1.00 (+25.0%)
Aug 7, 2026	Eric Sheridan	Goldman Sachs	Initiates Coverage	Hold	$3.50 → $4.00 +0.50 (+14.3%)
Aug 7, 2026	Parker Snure	Raymond James	Maintains	Buy	$4.50
Aug 7, 2026	Craig Hettenbach	Morgan Stanley	Reiterates	Hold	$3.00 → $4.00 +1.00 (+33.3%)
Aug 6, 2026	Michael Cherny	Leerink Partners	Maintains	Buy	$3.50 → $5.00 +1.50 (+42.9%)
Jul 26, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-

Allen Lutz

BofA Securities

SellMaintains

$2.65

Sep 15

Glen Santangelo

Barclays

SellMaintains

$3.00 → $4.00

Aug 20

Jailendra Singh

Truist

HoldReiterates

Aug 14

Kevin Caliendo

UBS

HoldMaintains

$2.50 → $3.75

Aug 13

Charles Rhyee

TD Cowen

BuyReiterates

$4.00 → $5.00

Aug 11

Daniel Grosslight

Citi

BuyMaintains

$4.00 → $5.00

Aug 11

Daniel Grosslight

Citi

BuyMaintains

$4.00 → $5.00

Aug 10

Eric Sheridan

Goldman Sachs

HoldInitiates Coverage

$3.50 → $4.00

Aug 7

Parker Snure

Raymond James

BuyMaintains

$4.50

Aug 7

Craig Hettenbach

Morgan Stanley

HoldReiterates

$3.00 → $4.00

Aug 7

Michael Cherny

Leerink Partners

BuyMaintains

$3.50 → $5.00

Aug 6

Zacks Equity Research

HoldInitiates Coverage

Jul 26

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for GDRX?

The analyst consensus rating for GDRX is Hold, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for GDRX?

The average 12-month price target for GDRX is $4.21, representing an upside of 25.3% from the Oct 16, 2026 close of $3.36.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.